Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

NCT00305812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: lenalidomide
DRUG: melphalan

Sponsor

NCIC Clinical Trials Group